Comitangelo Alessio, Vozza Alfredo, Ditaranto Giovanna, Re Giuseppe, Berloco Ada, Porfido Erasmo, Custodero Carlo, Comitangelo Domenico, Madaghiele Sara, Portacci Andrea, Tortorella Cosimo, Piazzolla Giuseppina
Interdisciplinary Department of Medicine, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.
Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", Bari, Italy.
Infect Dis Ther. 2025 Sep;14(9):2053-2070. doi: 10.1007/s40121-025-01200-8. Epub 2025 Jul 26.
Early prognostic stratification in patients hospitalized for acute infections is a major clinical challenge. Existing tools, such as the Sequential Organ Failure Assessment (SOFA) score and Charlson Comorbidity Index (CCI), were not specifically developed for this purpose.
We aimed to design a novel multidimensional prognostic score, the Acute Severity Infection score (ASIs), to predict in-hospital mortality using routinely available clinical data.
This retrospective cohort study included 149 adults admitted with acute infections to an internal medicine unit between January 2023 and December 2024. In-hospital all-cause mortality was the primary outcome. Demographic, clinical and laboratory variables obtained within 12 h of admission were analyzed. Variables significantly associated with mortality in both univariate and multivariate regression were incorporated into the ASIs, which ranges from 0 to 7 points. Its performance was compared to SOFA and CCI using ROC curve and Cox regression models.
In-hospital mortality occurred in 25.5% of patients. Five variables were independently associated with mortality: lactate ≥ 2.2 mmol/l, frailty composite (confined to bed status, long-term oxygen therapy or advanced malignancy), hemodynamic instability or need for non-invasive ventilation, age ≥ 79.5 years and symptom onset ≥ 3.5 days before admission. ASIs showed the highest discriminative ability (AUC = 0.883) compared to SOFA (AUC = 0.612) and CCI (AUC = 0.742). In multivariate models including all three scores, only ASIs retained independent prognostic significance.
The ASIs is a simple tool for early prognostic stratification of patients hospitalized with acute infections. It outperforms existing scores and may enhance clinical decision-making in real-world medical settings.
对因急性感染住院的患者进行早期预后分层是一项重大临床挑战。现有工具,如序贯器官衰竭评估(SOFA)评分和查尔森合并症指数(CCI),并非专门为此目的而开发。
我们旨在设计一种新型多维预后评分,即急性严重感染评分(ASIs),以利用常规可得的临床数据预测住院死亡率。
这项回顾性队列研究纳入了2023年1月至2024年12月期间因急性感染入住内科病房的149名成年人。住院全因死亡率是主要结局。分析入院后12小时内获得的人口统计学、临床和实验室变量。在单变量和多变量回归中与死亡率显著相关的变量被纳入ASIs,其范围为0至7分。使用ROC曲线和Cox回归模型将其性能与SOFA和CCI进行比较。
25.5%的患者发生了住院死亡。五个变量与死亡率独立相关:乳酸≥2.2 mmol/l、虚弱综合指标(卧床状态、长期氧疗或晚期恶性肿瘤)、血流动力学不稳定或需要无创通气、年龄≥79.5岁以及症状出现时间≥入院前3.5天。与SOFA(AUC = 0.612)和CCI(AUC = 0.742)相比,ASIs显示出最高的判别能力(AUC = 0.883)。在包括所有三个评分的多变量模型中,只有ASIs保留了独立的预后意义。
ASIs是一种用于对因急性感染住院患者进行早期预后分层的简单工具。它优于现有评分,可能会加强实际医疗环境中的临床决策。